Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (813)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
675
Price
$514.43
Total Value
$347.24K
Shares Held After
332,908
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
182
Price
$513.39
Total Value
$93.44K
Shares Held After
333,583
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
178
Price
$512.49
Total Value
$91.22K
Shares Held After
333,765
% of Holdings
0.1%
FATE THERAPEUTICS INC (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
38,800
Price
$2.46
Total Value
$95.41K
Shares Held After
589,355
% of Holdings
6.2%
Korro Bio, Inc. (KRRO)
Aiyar Ram — Director
Shares
5,802
Price
$10.84
Total Value
$62.92K
Shares Held After
69,046
% of Holdings
7.8%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
800,000
Price
$0.50
Total Value
$400.00K
Shares Held After
883,886
% of Holdings
90.5%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
2,611
Price
$24.64
Total Value
$64.34K
Shares Held After
117,227
% of Holdings
2.2%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
1,500
Price
$23.87
Total Value
$35.80K
Shares Held After
119,838
% of Holdings
1.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,967
Price
$24.65
Total Value
$73.13K
Shares Held After
40,166
% of Holdings
6.9%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
1,794
Price
$23.89
Total Value
$42.86K
Shares Held After
43,133
% of Holdings
4.0%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
653
Price
$2.94
Total Value
$1.92K
Shares Held After
268,371
% of Holdings
0.2%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
653
Price
$2.95
Total Value
$1.92K
Shares Held After
328,737
% of Holdings
0.2%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
3,023
Price
$2.95
Total Value
$8.91K
Shares Held After
1,260,890
% of Holdings
0.2%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
4,375
Price
$26.12
Total Value
$114.26K
Shares Held After
717,203
% of Holdings
0.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
955
Price
$26.12
Total Value
$24.94K
Shares Held After
119,289
% of Holdings
0.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
1,230
Price
$26.12
Total Value
$32.12K
Shares Held After
126,171
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
100
Price
$97.10
Total Value
$9.71K
Shares Held After
97,994
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,300
Price
$96.30
Total Value
$221.49K
Shares Held After
98,094
% of Holdings
2.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,100
Price
$95.21
Total Value
$485.57K
Shares Held After
100,394
% of Holdings
4.8%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
16
Price
$97.46
Total Value
$1.56K
Shares Held After
567,540
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
1,392
Price
$96.82
Total Value
$134.77K
Shares Held After
567,556
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,635
Price
$95.93
Total Value
$540.57K
Shares Held After
568,948
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
7,157
Price
$95.10
Total Value
$680.63K
Shares Held After
574,583
% of Holdings
1.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
800
Price
$93.97
Total Value
$75.18K
Shares Held After
581,740
% of Holdings
0.1%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
2,334
Price
$34.68
Total Value
$80.94K
Shares Held After
96,412
% of Holdings
2.4%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
1,000
Price
$33.98
Total Value
$33.98K
Shares Held After
98,746
% of Holdings
1.0%
ALUMIS INC. (ALMS)
Goldstein David M — Chief Scientific Officer
Shares
2,596
Price
$26.37
Total Value
$68.46K
Shares Held After
30,970
% of Holdings
7.7%
ALUMIS INC. (ALMS)
Hardiman Roy C. — Chief Business&Strategy Ofcr
Shares
2,692
Price
$26.37
Total Value
$70.99K
Shares Held After
207,746
% of Holdings
1.3%
ALUMIS INC. (ALMS)
Schroer John R. — Chief Financial Officer
Shares
3,282
Price
$26.37
Total Value
$86.55K
Shares Held After
24,718
% of Holdings
11.7%
ALUMIS INC. (ALMS)
Pangali Sanam — Chief Legal Officer
Shares
1,364
Price
$26.37
Total Value
$35.97K
Shares Held After
9,747
% of Holdings
12.3%
ALUMIS INC. (ALMS)
Bradley Mark Christopher — Chief Development Officer
Shares
2,572
Price
$26.37
Total Value
$67.82K
Shares Held After
48,533
% of Holdings
5.0%
ALUMIS INC. (ALMS)
Drappa Jorn — Chief Medical Officer
Shares
2,447
Price
$26.37
Total Value
$64.53K
Shares Held After
56,892
% of Holdings
4.1%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
1,540
Price
$114.16
Total Value
$175.81K
Shares Held After
5,495
% of Holdings
21.9%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
20,305
Price
$114.70
Total Value
$2.33M
Shares Held After
9,755
% of Holdings
67.5%
Camp4 Therapeutics Corp (CAMP)
Maricich Yuri — Chief Medical Officer
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
12,611
% of Holdings
51.9%
BeOne Medicines Ltd. (ONC)
Rosenberg Aaron — Chief Financial Officer
Shares
1,157
Price
$312.71
Total Value
$361.81K
Shares Held After
0
% of Holdings
100.0%
Camp4 Therapeutics Corp (CAMP)
Young Richard A — Director
Shares
16,378
Price
$1.65
Total Value
$27.02K
Shares Held After
186,388
% of Holdings
8.8%
Camp4 Therapeutics Corp (CAMP)
Gold Kelly — Chief Financial Officer
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
74,428
% of Holdings
8.8%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,389
Price
$54.09
Total Value
$75.13K
Shares Held After
157,541
% of Holdings
0.9%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
861
Price
$53.50
Total Value
$46.07K
Shares Held After
158,930
% of Holdings
0.5%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
3,044
Price
$54.18
Total Value
$164.92K
Shares Held After
105,176
% of Holdings
2.8%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
6,956
Price
$53.76
Total Value
$373.96K
Shares Held After
108,220
% of Holdings
6.0%
Camp4 Therapeutics Corp (CAMP)
Mandel-Brehm Josh — Director
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
284,968
% of Holdings
2.3%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance&Operations
Shares
275
Price
$1.98
Total Value
$543.68
Shares Held After
504,819
% of Holdings
0.1%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
75,000
Price
$0.94
Total Value
$70.59K
Shares Held After
1,983,551
% of Holdings
3.8%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,604
Price
$27.09
Total Value
$43.44K
Shares Held After
255,263
% of Holdings
0.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
30,304
Price
$26.71
Total Value
$809.54K
Shares Held After
256,867
% of Holdings
10.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
154
Price
$27.09
Total Value
$4.17K
Shares Held After
20,744
% of Holdings
0.7%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,439
Price
$26.71
Total Value
$65.16K
Shares Held After
20,898
% of Holdings
10.5%
Editas Medicine, Inc. (EDIT)
Parison Amy — SVP, Chief Financial Officer
Shares
678
Price
$2.58
Total Value
$1.75K
Shares Held After
14,292
% of Holdings
4.5%
Showing 51–100 of 813 transactions (page 2 of 17)